-
1دورية أكاديمية
المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, MarÃa J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, Galamaga, Rob
المصدر: ENT and Skull Base Surgery
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Progression-Free Survival, Protein Kinase Inhibitors, Quinolines, Sunitinib, Survival Analysis
الإتاحة: https://doi.org/10.1056/NEJMoa2035716Test
https://scholar.barrowneuro.org/ent-and-skull-base-surgery/23Test -
2دورية أكاديمية
المؤلفون: Solis-Hernandez, Mª Pilar, Fernandez Del Valle, Ana, Carmona-Bayonas, Alberto, Garcia-Carbonero, Rocio, Custodio, Ana, Benavent, Marta, Alonso Gordoa, Teresa, Nuñez-Valdovino, Bárbara, Sanchez Canovas, Manuel, Matos, Ignacio, Alonso, Vicente, Lopez, Carlos, Viudez, Antonio, Izquierdo, Marta, Calvo-Temprano, David, Grande, Enrique, Capdevila, Jaume, Jimenez-Fonseca, Paula
مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents, Confidence Intervals, Female, Humans, Male, Middle Aged, Neuroendocrine Tumors, Pancreatic Neoplasms, Progression-Free Survival, Proportional Hazards Models, Prospective Studies, Response Evaluation Criteria in Solid Tumors, Sunitinib, Tomography, X-Ray Computed, Tumor Burden, Young Adult
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/10668/14466Test; PMC6889276; https://www.nature.com/articles/s41416-019-0558-7.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889276/pdfTest
الإتاحة: https://doi.org/10.1038/s41416-019-0558-7Test
http://hdl.handle.net/10668/14466Test
https://www.nature.com/articles/s41416-019-0558-7.pdfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889276/pdfTest -
3
المؤلفون: Carmona-Bayonas, Alberto, Jiménez-Fonseca, Paula, Lamarca, Ángela, Barriuso, Jorge, Castaño, Ángel, Benavent, Marta, Alonso, Vicente, Riesco-Martínez, María del Carmen, Alonso-Gordoa, Teresa, Custodio, Ana, Sánchez Cánovas, Manuel, Hernando Cubero, Jorge, López, Carlos, Lacasta, Adelaida, Fernández Montes, Ana, Marazuela, Mónica, Crespo, Guillermo, Escudero, Pilar, Diaz, José Ángel, Feliciangeli, Eduardo, Gallego, Javier, Llanos, Marta, Segura, Ángel, Vilardell, Felip, Percovich, Juan Carlos, Grande, Enrique, Capdevila Castillón, Jaume, Valle, Juan W., García-Carbonero, Rocío, Universitat Autònoma de Barcelona
المساهمون: LEO Pharma, Ipsen, Pfizer, Roche, Amgen, Merck & Co, Merck Sharp & Dohme, AstraZeneca, Sanofi, Bayer, Eisai, Celgene, Novartis, Advanced Accelerator Applications, Bristol-Myers Squibb, UAM. Departamento de Medicina, Novartis Farmaceútica
المصدر: JOURNAL OF CLINICAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Digital.CSIC. Repositorio Institucional del CSIC
Biblos-e Archivo. Repositorio Institucional de la UAM
Carmona-bayonas, A, Jiménez-fonseca, P, Lamarca, Á, Barriuso, J, Castaño, Á, Benavent, M, Alonso, V, Riesco-martínez, M D C, Alonso-gordoa, T, Custodio, A, Sánchez Cánovas, M, Hernando Cubero, J, López, C, Lacasta, A, Fernández Montes, A, Marazuela, M, Crespo, G, Escudero, P, Diaz, J Á, Feliciangeli, E, Gallego, J, Llanos, M, Segura, Á, Vilardell, F, Percovich, J C, Grande, E, Capdevila, J, Valle, J W & García-carbonero, R 2019, ' Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study ', Journal of Clinical Oncology, pp. JCO.19.00980 . https://doi.org/10.1200/JCO.19.00980Test
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Journal of Clinical Oncology
Repisalud
Instituto de Salud Carlos III (ISCIII)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Feمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Octreotide, Neuroendocrine tumors, Lanreotide, THERAPY, Cohort Studies, chemistry.chemical_compound, 0302 clinical medicine, PROGNOSTIC-FACTORS, EVEROLIMUS, Gastrointestinal Cancer, prognostic model, Manchester Cancer Research Centre, ORIGINAL REPORTS, somatostatin analogs, Progression-Free Survival, Neuroendocrine Tumors, 030220 oncology & carcinogenesis, Female, lanreotide, Somatostatin, medicine.drug, Cohort study, NEOPLASMS, Adult, medicine.medical_specialty, Adolescent, Medicina, SUNITINIB, nomogram, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, Progression-free survival, Survival analysis, Retrospective Studies, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Retrospective cohort study, Nomogram, medicine.disease, Survival Analysis, Hormones, MODEL, 030104 developmental biology, chemistry, REGISTRY, business, octreotide
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8abca4a41dc814f6e3652d2060787a26Test
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7071Test